Management of placenta accreta spectrum disorders in COVID 19 patients

Rozi Aditya Aryananda, Albaro José Nieto-Calvache, Nareswari Imanadha Cininta, Citra Aulia Bachtiar, Manggala Pasca Wardhana, Lina Maria Vergara Galliadi, Adriana Messa Bryon, Juan Manuel Burgos Luna

Research output: Contribution to journalArticlepeer-review


Introduction: The COVID-19 pandemic has made it difficult to respond to demands in maternal health around the world. Placenta accreta spectrum (PAS) is one of the most severe obstetric conditions and usually requires the use of multiple health resources We describe the clinical results of the management of PAS patients during the COVID-19 pandemic and analyze how the pandemic may affect the functioning of a PAS team. Methodology: This was a descriptive, retrospective study including all patients treated for PAS in two low- to middle-income country reference hospitals between January 2020 and March 2021. The clinical results of patients with SARS-CoV-2 infection during PAS surgery (Group 1) were compared with those of PAS patients without SARS-CoV-2 infection (Group 2). Results: One hundred forty-five patients undergoing surgery for PAS were included. Group 1 patients (11 cases) showed a longer operative time (250 min, IQR 200–300) and a higher frequency of intra- or postoperative complications (54.5%) than group 2 patients (180 min [IQR 125–240], and 17.9%). Conclusion: Placenta accreta spectrum patients undergoing surgery during acute SARS-CoV-2 infection have a higher frequency of postoperative complications. PAS teams must prepare to modify their management protocols to minimize risks for patients and healthcare personnel.

Original languageEnglish
Pages (from-to)8844-8847
Number of pages4
JournalJournal of Maternal-Fetal and Neonatal Medicine
Issue number25
Publication statusPublished - 2022


  • COVID-19
  • Placenta accreta
  • SARS CoV-2
  • biosafety
  • personal protective equipment
  • postoperative complications


Dive into the research topics of 'Management of placenta accreta spectrum disorders in COVID 19 patients'. Together they form a unique fingerprint.

Cite this